chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Upon screening of second Moderna vaccine, patient reported that she had vision problem in the right eye after receiving her first vaccine.  She reported that it lasted for 5 minutes after administration.  I told her to inform me right away if she gets this again after 2nd vaccine.  She did not report any vision issues after 2nd vaccine administration.
Pt had previously tested positive for COVID on 01/08/21  She experienced prolonged symptoms after vaccination that included: vomiting, diarrhea, headache >4 days
1 hr following immun pt had sharp, piercing pain between shoulder blades; unable to sleep that noc; exp sharp pain; lt breast pain & pain in neck;
2 1/2 weeks after 1st dose, pain in right gastroc/politeal fossa while walking. Pain only on ambulation, none at rest. No signs of intermittent claudication. No cord, negative homan's sign, negative erythema. No history of trauma, osteoarthritis of the knee or Baker's cyst.  I applied heat daily and start 81 mg. of aspirin daily.  After 2 weeks this pain went away. However, within days of dose #2, I had a 7 day bout of colitis with mucus stools, chills, fatigue and myalgia. These symptoms passed. About 2 weeks after dose #2, the right leg pain returned and has not abated.  (second dose administered at a different Walgreens location)
Stiff and couldn't move arm 1 day after redness size bigger than softball and area was raised. Told patient to take BENADRYL and TYLENOL or MOTRIN. Left arm.
Pt recvd mumps vax 28APR99; On 18NOV90 2 yrs later, devel facial swelling of lt side of face; seen by MD dx w/mumps; later recovered; no further details were provided;
This spontaneous report was received from a nurse regarding a patient of unknown age and gender. There was no information on pertinent medical history and drug reactions or allergies. On an unknown date, the patient was vaccinated with (Oka/Merck) VARIVAX (dose, frequency, dose number, product lot #, expiry date not reported, strength reported as 1350, units reported as U) that was exposed to temperatures of 8 degrees Fahrenheit for 2 hours. There was no information on concomitant therapy. No adverse effects reported. There was no product quality complaint involved. The outcome of the event was unknown.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 11Feb2021 as dose 1, single (Lot number: EM266), in left arm, on 04Mar2021 as dose 2, single (Lot number: EN6206), in left arm and on 20Aug2021 as dose 3 (booster), single (Lot number: FC3182) at the age of 44 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Celiacs" (unspecified if ongoing), notes: Other medical history: Celiacs; "RA" (unspecified if ongoing), notes: Other medical history: RA; "Barretts" (unspecified if ongoing), notes: Other medical history: Barretts; "known allergies: Gluten" (unspecified if ongoing). Concomitant medication(s) included: DEXILANT, start date: 10Oct2016; LO LOESTRIN FE, start date: 22May2019. Past drug history included: Morphine, reaction(s): "known allergies: morphine"; Mucinex, reaction(s): "known allergies: mucinex". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of covid-19.Clinical Course: The second day of Paxlovid patient started itching all over and got a rash on patient's  leg and back. Patient Went to bed and woke up with a crippling headache. The taste of this medicine is absolutely horrendous. Every dose was like licking a rusted lead pipe
This spontaneous report was received from a Nurse Practitioner refers to a adult patient of unknown age and gender. No medical history was reported. On an unknown date in October 2012, patient received their first dose of RECOMBIVAX HB (lot#, expiry not reported), 0.5 ml, intramuscularly. On 29-MAR-2013, the patient was vaccinated later with dose 2 of RECOMBIVAX HB (lot#, expiry not reported), 0.5 ml, intramuscularly. No concomitant medications were reported. No adverse effects reported. Additional information has been requested.
Patient received vaccination and was directed with parent to the exit area. As parent was scheduling second dose, patient said he felt dizzy and sat on floor and lied down. Patient did not lose consciousness and continued to communicate with parent and staff. Patient was brought to a chair to sit in. Patient still complained of dizziness and was given a juice box and pretzels. Patient improved with food and drink. Patient was observed for 30 minutes before being released to the care of his parent.
Approx 2 wks following injection, L shoulder pain, followed by weakness of deltoid; mild residual shoulder pain lasted 8 wks. Approx 6 wks after shot, tingling of L thumb, wrist and forearm. Suspect brachial neuritis.
I have pain in the axilla region in the arm where I was given the shot this pain started shortly after  the initial pain from the injection subsided. My arm is also weak and I have been unable to have full range of motion, the swelling has not subsided.
Arm hot; Arm hurts to move it.; Headache; Exhausted like I have not slept; This is a spontaneous report received from a contactable other healthcare professional, the patient. A 38-year-old female patient received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6198) via an unspecified route of administration in the left arm on 16Mar2021 at 15:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergy (unspecified whether for medications or food or other products). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks prior to the vaccination. The patients past drug history included first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6200), via an unspecified route of administration in the left arm on 23Feb201 at 14:30, for COVID-19 immunisation. On 17Mar2021 at 02:30, the patient experienced arm hot, arms hurt to move it, headache and exhausted like I have not slept. The clinical outcome of the events arms hot, arms hurt to move, headache and exhausted like patient had not slept was recovering. No follow-up attempts are needed. No further information is expected.
Blister-like hives appeared on tops of ears, then upper back and back of hand; Sore arm; Nausea; Fatigue; Tremors; Headache; Vomiting; This is a spontaneous report from a contactable consumer (patient). A 12-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number and Expiration Date: unknown), dose 1 via an unspecified route of administration, administered in Arm Right on 14May2021 09:00 as single dose for COVID-19 immunization. The patient medical history and concomitant medication was not reported. The patient previously had the known allergies included hives developed after 1 dose of amoxicillin and Azithromycin, hives present after several doses of m (as reported). The patient did not have the COVID prior vaccination and was not tested for COVID post vaccination. The patient did not receive other vaccine in four weeks. The patient received Multivitamin and Probiotic in two weeks. On 14May2021 at 01:00 PM, after the 4 hours of dose the patient experienced blister-like hives appeared on tops of ears, then upper back and back of hand. Then, sore arm, nausea, fatigue, tremors, headache through night. Following day continued with hives, headache, fatigue, sore arm, plus vomiting. Felt much better by the second day post shot. Just hives and arm soreness continued. The patient did not receive treatment for the events. On an unspecified date, the events nausea, fatigue, vomiting, tremors and headache were resolved. The outcome of blister-like hives appeared on tops of ears, then upper back and back of hand and sore arm were not resolved.  Information on lot/batch number has been requested.
Site pain and swelling, under arm swelling and soreness that began the day after the vaccine. Swelling increased over next four days to the point of fluid build up in L arm, L breast, L back, L shoulder causing shortness of breath and discomfort. I followed up with my PCP due to the shortness of breath and continued swelling.
nurse cut an unspecified finger on GARDASIL 9 syringe; nurse cut an unspecified finger on GARDASIL 9 syringe that the finger flange had broken off; the finger flage had broken off; the nurse did not notice the broken finger flange until she administered the vaccine to a patient; nurse cut an unspecified finger on GARDASIL 9 syringe that the finger flange had broken off; This spontaneous report was received from a registered nurse referring to a female patient of unknown age. No information was provided regarding the patient's medical history, concurrent conditions, concomitant medications, drug reactions and allergies.  On 13-NOV-2019, the nurse cut an unspecified finger on a hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot number R027576  and expiration date on 23-JUN-2021 for prophylaxis) (dose, dose number, route of administration and anatomical injection site were not reported) syringe that the finger flange had broken off (skin laceration, injury, accidental exposure to product and syringe issue). The nurse cleansed the finger with an unspecified antiseptic wash, applied and unspecified antibiotic cream and unspecified bandage. The nurse did not notice the broken finger flange until she administered the vaccine to a patient (poor quality product administered). The patient sought for medical attention and no diagnostic laboratories or studies were performed.  At the time of the report, the patient recovered from the events and the causality assessment between hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9)  with skin laceration and injury was not reported.
"Covid Arm"- Delayed reaction at injection site 10 days after injection.  3 to 4 inch circumference red, irritated and itchy.
I run a satellite clinic currently and receive necessary doses of vaccines from the main Clinic. I was sent 1 bottle of monovalent Moderna vaccine. I had 1 pt on the schedule for an initial vaccination. This patient and his wife came in desiring boosters of Covid vaccine. He reports receiving 2 doses of Pfizer last year.  I explained we didn't have the multivalent dose as I was told it was not available yet, and received just the monovalent vaccine. The patient and his wife both elected to receive this vaccine and would wait for the multivalent vaccine when it was available. I was asked by the clinic to submit this variance report.
p/vax pt exp sz & diarrhea; hosp; per mom-T101.6; pt unresponsive & unconscious; ER; hosp; abd pain; & vomit x1; per MD-limp, apneic, pale;eyes rolled back;dec resp effort; hosp; disch w/apnea monitor;
Patient received Moderna vaccine dose (0.5 mL instead of 0.25 mL) and lot number indicated for patients age 6-11, but patient was 5 years and 1 month at the time of vaccination  There were no symptoms or signs of adverse event observed during waiting period after patient was vaccinated
Patient admitted with non-intractable vomiting and found to have COVID-19.  Patient still undergoing hospital treatment.
I received the GARDASIL vaccine January 2013 and I almost automatically felt side effects, the side effects included the following: headaches, dizziness, nausea, vomiting, anxiety, and blurry vision.
Patient received Fluad instead of a standard dose flu as indicated by age.  Patient does not have any side effects noted.
COVID-19 Treatment; COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 54-year-old male patient received BNT162b2 (BNT162B2), on 10May2022 as dose 4 (booster), single (Lot number: FM992) at the age of 53 years for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 21Feb2021 as dose 1, single (Lot number: 012M20A), on 13Mar2021 as dose 2, single (Lot number: 002B21A) and on 24Oct2021 as dose 3 (booster), single (Lot number: 939906) for covid-19 immunisation. The patient's relevant medical history included: "coronary heart disease" (unspecified if ongoing). Concomitant medication(s) included: ATORVASTATIN, start date: 01Feb2022, stop date: 15Aug2022; CLOPIDOGREL, start date: 01Feb2022; FAMOTIDINE, start date: 01Feb2022; FLUTICASONE, start date: 01Oct2021, stop date: 15Aug2022.  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), DISEASE RECURRENCE (medically significant), outcome "unknown" and all described as "COVID-19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of vaccination failure, covid-19, disease recurrence.No known allergies reported.
Immunizations (DTaP, Hib, MMR, flu) given at 11:30 am at well child visit. Developed fever from 2pm - 7pm. Slept a lot. Mom gave TYLENOL through the day because febrile seizures run in family. Had seizure at 9:50 pm (when NOT febrile). Seizure lasted about 2 minutes. Mom spoke with on-call pediatrician shortly after seizure. Stated he seemed fine now. Was seen following day in clinic. Discussed with neuro. Seizure med prescribed for any possible future seizure.
Expired vaccine used; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 05-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided. No symptoms or quality issues were reported.   Most recent FOLLOW-UP information incorporated above includes: On 22-Nov-2021: Patient initials and Event related information were updated. On 25-Nov-2021: Significant information received and updated dose number of the vaccine.
It was reported to this writer by the safety officer that the patient complained of palpitations toward the end of the standard 15 minute wait time.. EMS was called to see patient.  Patient was conversing  with EMS throughout their exam. Vital signs were WNL. EMS recommended that the patient stay an additional 15 minutes.  Patient was discharged by EMS as OK to go home. No further complaints Palpitations resolved.
lots of joint pain; I had chills; I had lots of body ache/ my arm went sore; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (lots of joint pain), CHILLS (I had chills) and MYALGIA (I had lots of body ache/ my arm went sore) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced ARTHRALGIA (lots of joint pain), CHILLS (I had chills) and MYALGIA (I had lots of body ache/ my arm went sore). On 12-Feb-2021, ARTHRALGIA (lots of joint pain), CHILLS (I had chills) and MYALGIA (I had lots of body ache/ my arm went sore) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included generic of Flonase for sinuses, vitamin C and vitamin D. Treatment information was not provided.
This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hive-like rash, hives on stomach), SKIN WARM (left hand warm), INFLAMMATION (left hand inflamed) and RASH (spreading rash (left forearm), rash on left forearm and hand areas) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for an unknown indication. On 03-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced URTICARIA (hive-like rash, hives on stomach), SKIN WARM (left hand warm), INFLAMMATION (left hand inflamed) and RASH (spreading rash (left forearm), rash on left forearm and hand areas). At the time of the report, URTICARIA (hive-like rash, hives on stomach), SKIN WARM (left hand warm), INFLAMMATION (left hand inflamed) and RASH (spreading rash (left forearm), rash on left forearm and hand areas) outcome was unknown. Not Provided. Patient was placed on a prednisone taper. Treatment information provided was drug free allergy relief product. Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: Significant follow up vaccination date.
This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (rapid heart beat) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. Concurrent medical conditions included Asthma. Concomitant products included SALBUTAMOL SULFATE (PROAIR [SALBUTAMOL SULFATE]) for Asthma. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced TACHYCARDIA (rapid heart beat). On 31-Jan-2021, TACHYCARDIA (rapid heart beat) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment for the event not reported.
Patieint underwent a repeat low transverse cesarean section delivery without complication and was stable postoperatively on date. Hospital admission within 6 weeks of receiving the COVID vaccine.
+3-4hrs started feeling tired (not as bad as the first dose, but noticeably tired and hard to focus) +12hrs I woke up around 11 PM shivering uncontrollably (I woke my wife up because I was shaking the bed). I was shaking so much that it was literally making me feel nauseous, the jolting of my abdomen muscles were causing my stomach to get uneasy and everything hurt. Every joint felt like I had arthritis, and every inch of my skin was sore like I had a really bad sunburn head to toe. +13hrs I spiked a 103.1º fever (while on extra strength Tylenol) +24hrs I woke up around 12 noon feeling a bit better. Fever dropped to high 99's, body aches subsided, and skin soreness was gone almost completely. But a new dull, but persistent headache was there. +36hrs I started getting the chills again around 8PM on the second day and my fever rose to 100.6º +48hrs I woke up feeling like nothing ever happened aside from some slight soreness around the injection site.
I received two vaccines in right upper arm on the same day. I felt fine until a few hours later. I became dizzy and light headed. The next morning I woke up with flu-like symptoms and remained dizzy. I called the Health Department and I was informed that the side effects were normal. Today is the fourth day after receiving the vaccines. I remain with dizzy light headedness, flu-like symptoms and now have a low grade fever of 99.4 that I did not have on the previous days. The dizziness has increased each day and now feels like tingling in my fingers and arms. I spoke to a nurse today and was told that the side effects are normal. It does not feel right or normal, and it frightens me. I believe I am having adverse side effects, especially with the dizziness. I thought that the side effects were important enough to report.
Patient reported on 04/09/2019 in morning that she had a reaction. She was having mild fever, pain all over the body, could not sleep, head cold and congestion. She took tylenol for pain and fever.
Information has been received from a registered nurse concerning a 22 year old female with sulfonamide allergy and a penicillin allergy who on 18-APR-2008 was vaccinated intramuscularly with the first dose of GARDASIL (lot # 660389/1968U). Concomitant therapy included LEVAQUIN, PREVACID (patient given prescription on 18-APR-2008) and SEASONIQUE. On 18-APR-2008, the patient experienced lightheadedness, dizziness, menstrual-like cramping and spotting. The patient also started LEVAQUIN on that day. On 19-APR-2008, the patient recovered from lightheadedness, dizziness, menstrual-like cramping and spotting. The patient did not seek medical attention. No product quality complaint was involved. Additional information has been requested.
10-15cm diameter redness, tender area;no abscess formation;started 24hr p/shot, resolved p/3-4days;
After standing up from the toilet early in the morning, fainted and fell on bathroom floor. No injuries were sustained. After regaining consciousness less than 1 minute later, sat up and breathed and focused for about 2 minutes until mentally clear. Relocated with assistance to couch, drank water, ate a slice of toast.
"Some soreness" after Vaccination; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious), outcome "unknown", described as ""Some soreness" after Vaccination".  Additional information: Reporter did not consider event as caused by suspect product(s)  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021466838 same product/event, different patients
Intense itching, hypersensitive skin, macular rash on middle of back and left groin. Diagnosis: shingles on 01/17/2014 started famvistatin.
Headache, nausea, joint pain, arm pit pain, shoulder and neck pain, tiredness, feeling unwell
Left arm swollen from elbow to shoulder, took BENADRYL, it went away after a few days.
Five days after receiving the first dose patient was admitted to Hospital on 03/30/2021 with an acute left MCA M2 branch stroke requiring tPA that resulted in a small amount of hemorrhagic transformation. Tee revealed no cardiac source of embolism. He is left with some expressive and receptive aphasia. He also has some loss of L eye vision. There was no stenosis of the carotid arteries but the left M2 branch was occluded. He did not have any atrial fibrillation in the hospital but is wearing a 30 day monitor currently.   We have no idea this was related to the vaccine but wanted to report. The Neurologist thinks it is just a coincidence.  But we still want you to know it happened.